Invention Grant
- Patent Title: Implantable device for sustained release of a macromolecular drug compound
-
Application No.: US18315605Application Date: 2023-05-11
-
Publication No.: US11951215B2Publication Date: 2024-04-09
- Inventor: Christian Schneider
- Applicant: Celanese EVA Performance Polymers LLC
- Applicant Address: US TX Irving
- Assignee: Celanese EVA Performance Polymers LLC
- Current Assignee: Celanese EVA Performance Polymers LLC
- Current Assignee Address: US TX Irving
- Agency: Dority & Manning, P.A.
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K38/39 ; A61K38/48

Abstract:
An implantable device for delivery of a macromolecular drug compound is provided. The device comprises a core having an outer surface and a membrane layer positioned adjacent to the outer surface of the core. The core comprises a core polymer matrix within which is dispersed a drug compound having a molecular weight of about 0.5 kDa or more, the polymer matrix containing a hydrophobic polymer. Further, the membrane layer comprises a membrane polymer matrix within which the macromolecular drug compound is optionally dispersed. The concentration of the macromolecular drug compound in the core is greater than the concentration of the macromolecular drug compound in the membrane layer.
Public/Granted literature
- US20230277470A1 Implantable Device for Sustained Release of a Macromolecular Drug Compound Public/Granted day:2023-09-07
Information query